We are changing the paradigm of immunotherapies with our next-generation multi-specific antibodies
AutoRegulation platform
NovalGen’s proprietary groundbreaking AutoRegulation technology platform enables the maximum efficacy to be unleashed from a therapy whilst ensuring a manageable safety profile by limiting life threatening toxicities.
Key capabilities
Novalgen is a fully integrated company capable of developing breakthrough therapies.
